1. Home
  2. NCNA vs YOSH Comparison

NCNA vs YOSH Comparison

Compare NCNA & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • YOSH
  • Stock Information
  • Founded
  • NCNA 1997
  • YOSH 2016
  • Country
  • NCNA United Kingdom
  • YOSH United States
  • Employees
  • NCNA N/A
  • YOSH N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • NCNA Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • NCNA 4.5M
  • YOSH N/A
  • IPO Year
  • NCNA 2017
  • YOSH 2022
  • Fundamental
  • Price
  • NCNA $0.10
  • YOSH $16.30
  • Analyst Decision
  • NCNA Buy
  • YOSH
  • Analyst Count
  • NCNA 2
  • YOSH 0
  • Target Price
  • NCNA $25.00
  • YOSH N/A
  • AVG Volume (30 Days)
  • NCNA 13.0M
  • YOSH 18.5K
  • Earning Date
  • NCNA 05-19-2025
  • YOSH 05-05-2025
  • Dividend Yield
  • NCNA N/A
  • YOSH N/A
  • EPS Growth
  • NCNA N/A
  • YOSH N/A
  • EPS
  • NCNA N/A
  • YOSH N/A
  • Revenue
  • NCNA N/A
  • YOSH $13,539,317.00
  • Revenue This Year
  • NCNA N/A
  • YOSH N/A
  • Revenue Next Year
  • NCNA N/A
  • YOSH N/A
  • P/E Ratio
  • NCNA N/A
  • YOSH N/A
  • Revenue Growth
  • NCNA N/A
  • YOSH 41.82
  • 52 Week Low
  • NCNA $0.10
  • YOSH $2.71
  • 52 Week High
  • NCNA $10.79
  • YOSH $22.50
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 35.71
  • YOSH 55.74
  • Support Level
  • NCNA $0.41
  • YOSH $14.94
  • Resistance Level
  • NCNA $0.42
  • YOSH $18.54
  • Average True Range (ATR)
  • NCNA 0.14
  • YOSH 1.61
  • MACD
  • NCNA -0.05
  • YOSH 0.32
  • Stochastic Oscillator
  • NCNA 0.43
  • YOSH 70.41

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: